Larimar Therapeutics

LRMRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$432.153 M

$4.16 -0.95%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$165.7M

Loss-making

Shares outstanding

103,882,937

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#216Puma BiotechnologyPBYI$453.5M
#217RezoluteRZLT$451.6M
#218Larimar TherapeuticsLRMR$432.2M
#219Assembly BiosciencesASMB$424.0M
#220Atea PharmaceuticalsAVIR$420.1M

Where these numbers come from

Share counts and financials for Larimar Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.